Risk Management Plan (RMP) & REMS Services

Is Your Risk Management Plan Up to Date With Your Product's Safety Profile?

A Risk Management Plan is only useful if it reflects what you know about your product today. Jeyflex develops and maintains Risk Management Plans and risk minimization programs across the full lifecycle, from first draft and submission through to tracking whether your measures are actually working.

What is a Risk Management Plan (RMP)?

A Risk Management Plan (RMP) is a detailed document that describes the risk management system for a medicinal product. It sets out the identified risks, potential risks, and gaps in knowledge, and describes the measures taken to minimize those risks and the way their effectiveness will be monitored and assessed.

 
An RMP that is not kept current leaves organizations exposed to:

Safety concerns that are known internally but not reflected in the RMP
Risk minimization measures that are in place but never evaluated for effectiveness
Gaps between the RMP, the PSUR, and the product information
Regulatory queries that a current, well-evidenced plan would have answered

Jeyflex builds RMPs that are practical to run, clear to regulators, and kept in step with your safety data.

Illustration depicting pharmaceutical risk management strategy with charts and graphs - Jeyflex

How Jeyflex Manages Your Risk Management Plan

We cover the complete RMP lifecycle, following the structure set out in GVP Module V, from the first assessment through to evaluating whether your measures work.

01

RMP Assessment & Planning

We review your product’s safety data and any existing RMP, confirm what each target market requires, and agree a plan and timeline before any drafting begins.

02

Safety Specification

We document the identified risks, potential risks, and missing information for your product, so the plan is built on a clear, evidence-based picture of its safety profile.

03

Pharmacovigilance Plan

We define the routine and additional pharmacovigilance activities, including Post-Authorization Safety Studies (PASS) where needed, that will close the knowledge gaps identified in the specification.

04

Risk Minimization Plan

We set out the routine measures, such as product labeling and Product Information Leaflets (PILs), and any Additional Risk Minimization Measures (aRMM) needed for specific safety concerns.

05

Submission & Authority Queries

We prepare the submission for each Health Authority, adapt the plan to local regulatory requirements, and support you through any questions or requests for changes.

06

Tracking & Effectiveness Evaluation

We track the measures in place, assess whether they are working, and update the RMP when new safety information or evaluation results require it.

Additional Risk Minimization Measures (aRMM)

Where routine measures are not enough to manage a specific safety concern, additional risk minimization measures may be needed. Jeyflex supports the full aRMM process:

Customization to align with local regulatory requirements
Careful preparation of submissions for Health Authority approval
Targeted distribution to the relevant stakeholders
Tracking and assessment to confirm the measures are effective

Risk management goes beyond documentation. We also incorporate key safety information into PILs, support Post-Authorization Safety Studies, and help deliver educational and support programs for healthcare professionals and patients.

Why Choose Jeyflex for Risk Management Plans?

Full Lifecycle Coverage

From initial writing and submission through to ongoing tracking and evaluation of effectiveness, one team handles every stage of your RMP.

Local Regulatory Alignment

We adapt your plan to the requirements of each market, including PPB, NDA, EFDA, RFDA, TMDA, NAFDAC, SAHPRA, and other African authorities.

Practical Application, Not Just Paperwork

Risk management only works when it reaches the people who use your product. We turn the plan into PIL content, studies, and education programs for healthcare professionals and patients.

Connected to Your PV System

Your RMP draws on signal management, case data, and PSUR findings, and feeds back into them, so the whole pharmacovigilance system tells one consistent story.

ISO 9001:2015 Certified

Every RMP is prepared and reviewed under our ISO 9001:2015 certified quality management system, so the process is consistent and documented.

Scalable to Your Portfolio

Whether you have one product in one market or a portfolio across many, we scale our RMP services to your products, markets, and regulatory footprint.

Our Risk Management Services

A complete set of services to develop, submit, maintain, and evaluate your risk management plans.

RMP gap assessment and review of existing plans
RMP writing, including safety specification and pharmacovigilance plan
Risk minimization plan development
Additional Risk Minimization Measures (aRMM) design and approval support
Local adaptation of RMPs to national regulatory requirements
RMP submission and Health Authority query support
Distribution of educational materials to healthcare professionals and patients
Product Information Leaflet (PIL) updates reflecting risk information
Post-Authorization Safety Study (PASS) support
Effectiveness tracking and ongoing RMP updates

What Happens When Your RMP Falls Behind?

An RMP is a living document. When it stops reflecting reality, the gaps tend to surface at the worst moments:

Requests from regulators for updates you cannot quickly support
Product information and PILs that do not match the current risk picture
Risk minimization measures distributed with no evidence they work
Inconsistencies between the RMP, PSUR, and signal records noted at inspection
Safety risks that reach patients because the right information did not reach prescribers

Risk management is not a one-time submission. It has to evolve with your product’s safety data for as long as the product is on the market.

Frequently Asked Questions

An RMP describes the safety profile of a medicinal product and how its risks will be managed. It typically includes a safety specification (identified risks, potential risks, and missing information), a pharmacovigilance plan covering the activities that will address those gaps, and a risk minimization plan describing the measures used to reduce risks and how their effectiveness will be assessed.

An RMP is the risk management document used under EU-style pharmacovigilance rules, which many regulators follow or reference. A Risk Evaluation and Mitigation Strategy (REMS) is the US FDA’s equivalent framework, applied to selected products with serious safety concerns. Which one applies depends on the market where the product is authorized. Jeyflex advises on the right approach for each target market.

An RMP should be updated whenever significant new safety information emerges or when the risk minimization measures change. It is also updated when a regulator requests it, or when your signal management, PSUR, or study results change the safety picture. Jeyflex monitors these triggers so your plan stays aligned with your safety data.

Additional risk minimization measures are interventions beyond routine labeling and product information, used when routine measures are not enough to manage a specific risk. Examples include educational materials for healthcare professionals or patients, and controlled distribution arrangements. They usually need Health Authority approval, and their effectiveness should be tracked. Jeyflex supports design, approval submissions, distribution, and effectiveness assessment.

Yes. We take an existing global RMP and adapt it to the requirements of each African market where the product is registered, including local aRMM and submission formats where an authority expects them. Requirements vary by country, and we advise on what applies in each market you operate in.

Keep Your Risk Management Plan Working for You

Whether you need a new RMP written, an existing plan reviewed and updated, or help designing and tracking additional risk minimization measures, Jeyflex is ready to help.